sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 3-Phenyl-1,2-oxazole

3-Phenyl-1,2-oxazole

CAS No.:
1006-65-1
Catalog Number:
AG0002FT
Molecular Formula:
C9H7NO
Molecular Weight:
145.1580
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
96%
In Stock USA
United States
$94
- +
5g
96%
In Stock USA
United States
$400
- +
10g
96%
In Stock USA
United States
$725
- +
Product Description
Catalog Number:
AG0002FT
Chemical Name:
3-Phenyl-1,2-oxazole
CAS Number:
1006-65-1
Molecular Formula:
C9H7NO
Molecular Weight:
145.1580
MDL Number:
MFCD00464218
IUPAC Name:
3-phenyl-1,2-oxazole
InChI:
InChI=1S/C9H7NO/c1-2-4-8(5-3-1)9-6-7-11-10-9/h1-7H
InChI Key:
ZBRDJMFLJXFIGJ-UHFFFAOYSA-N
SMILES:
c1ccc(cc1)c1nocc1
Properties
Complexity:
121  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
145.053g/mol
Formal Charge:
0
Heavy Atom Count:
11  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
145.161g/mol
Monoisotopic Mass:
145.053g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
26A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2  
Literature
Title Journal
Synthesis and biological evaluation of isoxazole, oxazole, and oxadiazole containing heteroaryl analogs of biaryl ureas as DGAT1 inhibitors. European journal of medicinal chemistry 20120801
Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. Journal of medicinal chemistry 20120126
Phenyl isoxazole voltage-gated sodium channel blockers: structure and activity relationship. Bioorganic & medicinal chemistry letters 20110701
Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. The Biochemical journal 20110515
Use of the nitrile oxide cycloaddition (NOC) reaction for molecular probe generation: a new class of enzyme selective histone deacetylase inhibitors (HDACIs) showing picomolar activity at HDAC6. Journal of medicinal chemistry 20080814
Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II 'selective' inhibitor celecoxib. Bioorganic & medicinal chemistry letters 20060115
Properties